Prostate Cancer - Results from #160

[225Ac]Ac-PSMA for the treatment of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis. November 19, 2024

Association between beta-blocker atenolol use and prostate cancer upgrading in active surveillance. November 19, 2024

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer. November 19, 2024

The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer. November 19, 2024

St Vincent’s Hospital to Conduct Head-to-Head Trial with Clarity’s SAR-bisPSMA Diagnostic Product November 18, 2024

Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers. November 18, 2024

HSD3B1, prostate cancer mortality and modifiable outcomes. November 18, 2024

Surgical Castration as an Alternative to Improve Systemic Treatment for Advanced Prostate Cancer: A Window of Opportunity for Developing Countries. November 18, 2024

PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177Lu-PSMA-617: Importance of 18F-FDG-Avid Discordant Findings. November 18, 2024

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials. November 18, 2024

Real-World Comparison of Cabazitaxel Versus 177Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer. November 18, 2024

Striving for Equity: Examining Health Disparities in Urologic Oncology. November 18, 2024

Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review. November 15, 2024

Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort. November 15, 2024

Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical Trial. November 15, 2024

Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216. November 15, 2024

The Role of Nuclear Medicine in Imaging and Therapy of Prostate Cancer: The State of the Art. November 15, 2024

A Novel Machine Learning-Based Predictive Model of Clinically Significant Prostate Cancer and Online Risk Calculator. November 15, 2024

PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial. November 14, 2024

A pilot randomized clinical trial of a smartphone-based application to support at-home PSA screening and culturally tailored prostate cancer education for African American men: A study protocol. November 14, 2024

Page 9 of 1447